-
Miltefosine, sold
under the
trade name
Impavido among others, is a
medication mainly used to
treat leishmaniasis and free-living
amoeba infections such...
-
United States utilized the
medication miltefosine. In one of the cases, a 12-year-old
female was
given miltefosine and
targeted temperature management to...
- sulfadiazine, azithromycin/clarithromycin, fluconazole, flucytosine, and
miltefosine) but
progressed negatively. Therefore, with the
permission of the FDA...
- "Treatment of
Granulomatous Amoebic Encephalitis with
Voriconazole and
Miltefosine in an
Immunocompetent Soldier". The
American Journal of
Tropical Medicine...
-
Diseases initiative (DNDi) in 2010.
Miltefosine is the
first oral
treatment for this disease. The cure rate of
miltefosine in
Phase III
clinical trials is...
-
neoplastic growth with
necrosing portions.
There is a weak
evidence that 6%
miltefosine solution applied topically on
superficial fungating breast lesions of...
-
Ribavirin Diloxanide Metronidazole Amphotericin B
Meglumine antimoniate Miltefosine Paromomycin Sodium stibogluconate Amodiaquine Artemether Artemether/lumefantrine...
-
discontinued due to the
emergence of
antifungals with
fewer side
effects Miltefosine works by
damaging fungal cell
membranes Nikkomycin –
blocks formation...
-
paromomycin is recommended. These, however, can have
significant side effects.
Miltefosine, an oral medication, is
effective against both
visceral and cutaneous...
-
fatality rate is
greater than 97%. New
treatments are
being sought.
Miltefosine, an
antiparasitic drug that
inhibits the
pathogen via
disrupting its...
